Protocol · graded by use, nine uses
Morning bright light (light box or daylight) for sleep and the body clock
Body clock timing (melatonin onset) moved earlier, healthy adults.
At a glance
This page is about bright light in the morning and sleep. In careful trials, bright light soon after waking made the body clock run earlier, measured by when a sleep hormone rises at night. That is a sign of the clock, not better sleep. For sleep itself, results are small and mixed. In one larger trial of older people with sleep trouble, bright morning light did no better than dim light. In one trial of older people with memory problems, bright light right after waking made them sleep less. No trial has tested going outside soon after waking in healthy people.
- What was measured
- When the body clock's evening sleep hormone rose, and in other trials, sleep measured by a wrist device or a sleep lab.
- How big
- Bright morning light moved the evening rise of the sleep hormone earlier by 2.1 hours, against 0.6 hours in dim light.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 12932084.
- Who it applies to
- Healthy young adults for the body clock; sleep results come from older adults, people with insomnia and care home residents.
- Safety
- In older adults with memory problems, bright light right after waking cut their sleep.
- Compared with
- Dim indoor light, or the same light at another time of day.
- Certainty
- Grade B, resting on: Randomized laboratory and clinical trials and meta-analyses A study that pools the numbers from several trials into one combined estimate. of them; population studies of personal light exposure, mood, sleep and mortality are listed as excluded evidence and carry no letter.
- What would change this grade
- Could rise to A with: Randomized controlled trial People are assigned to the treatment or a comparison by chance, so the groups differ only in what they received. It is the design that can show cause and effect. of outdoor or bright light within 30 to 60 minutes of waking against the same light later in the day or usual routine. Who: Healthy adults without sleep or mood disorders, several hundred per arm, with chronotype recorded. Measured: Sleep by actigraphy or polysomnography, daytime sleepiness and reaction time, with melatonin timing as a secondary marker. Length: At least 8 weeks.
- Cost
- No price recorded yet.
- Sources
- 38 studies cited on this record, listed under Sources.
The B belongs to one of the nine uses graded on this record. The other eight carry their own letters.
This record carries a separate letter for each thing it has been measured on. The headline grade is the best of them, and it does not transfer to the others.
Burgess et al. (Journal of Biological Rhythms, 2003; PMID 12932084): 28 healthy young adults on a sleep schedule advanced 1 hour a day for 3 days; the dim light melatonin onset (DLMO) moved earlier by 2.1 hours with continuous bright light and 1.5 hours with intermittent bright light in the first 3.5 hours after waking, against 0.6 hours in dim light (p < 0.01). Burke et al. (Sleep, 2013; PMID 24179293): randomized, placebo-controlled, double-blind Neither the participants nor the people assessing them know who received the real treatment until the trial ends. laboratory protocol in 36 healthy adults; morning bright light alone and evening melatonin alone gave similar phase advances, and the two together gave a larger advance. Friedman et al. (Journal of the American Geriatrics Society, 2009; PMID 19187411): scheduled light shifted circadian phase predictably in older adults with insomnia. Limits: Sharkey et al. (Sleep Medicine, 2011; PMID 21704557) found 1 hour of morning blue light (about 225 lux) added nothing to an earlier fixed sleep schedule (advances 1.4 against 1.5 hours), and Crowley et al. (Chronobiology International, 2018; PMID 30084658) found late bedtimes prevented the advance in 6 adolescents. The laboratory phase response curve (Khalsa et al., Journal of Physiology, 2003; PMID 12717008) shows the direction of the shift depends on the body's internal clock, not on clock time. Melatonin timing is a surrogate marker A lab value or measurement used in place of the outcome that matters, such as LDL cholesterol standing in for heart attacks. Moving a surrogate does not always move the outcome. of the clock, which caps the row at B.
Meta-analyses mixing morning and evening light lean positive with small effects: Chambe et al. (Journal of Sleep Research, 2023; PMID 37002704), 22 studies, 685 participants: wake after sleep onset improved (11.2 minutes by actigraphy), with no effect on sleep latency, total sleep time or sleep efficiency; Wang et al. (Sleep and Breathing, 2024; PMID 39733392), 10 randomized trials: total sleep time 16.78 minutes longer and wake after sleep onset 12.91 minutes shorter by actigraphy, with questionnaire scores improved; van Maanen et al. (Sleep Medicine Reviews, 2016; PMID 26606319): insomnia g = 0.47, with larger effects at higher intensity and signs of publication bias. Wasilah et al. (International Journal of Nursing Studies, 2026; PMID 42263407), limited to morning blue light, 14 articles, 444 people with insomnia, most with a neurological or medical illness: modest improvements in sleep quality and several objective measures, no change in total sleep time or fatigue. The largest placebo-controlled trial of morning light in primary insomnia, Friedman et al. (Journal of the American Geriatrics Society, 2009; PMID 19187411), 51 adults aged about 64 for 12 weeks, found bright light no better than dim light on polysomnography, actigraphy or sleep logs. Smaller morning-light trials were positive (Guilleminault et al., Archives of Internal Medicine, 1995; PMID 7717792, 30 patients; Yoon et al., Medicina, 2023; PMID 37374270, 14 patients, daytime sleepiness only). Mixed results, with the best-controlled morning trial null: C.
Faulkner et al. (Sleep Medicine Reviews, 2019; PMID 31108433), 40 controlled studies in circadian rhythm sleep disorders and psychiatric illness: light advanced delayed sleep timing (effect size How large a difference the treatment made, as distinct from whether the difference could be detected at all. -0.34) and improved sleep continuity (-0.23); van Maanen et al. (2016; PMID 26606319): effects for circadian rhythm sleep disorders were smaller in randomized trials. Rosenthal et al. (Sleep, 1990; PMID 2267478): 2 hours of morning bright light with evening light restriction advanced temperature rhythms and sleep latency in 20 patients. Richardson et al. (Sleep Medicine, 2018; PMID 29680419), 60 people aged 13 to 24: green bright light did no better than red light; all groups improved. Wilhelmsen-Langeland et al. (Journal of Biological Rhythms, 2013; PMID 24132057): over 2 weeks bright light, melatonin and placebo An inactive substitute made to look like the real treatment, so participants cannot tell which one they received. with earlier rise times were almost equally effective. Trials that combined light with other measures were positive but cannot isolate light: Gradisar et al. (Sleep, 2011; PMID 22131604), cognitive behavioral therapy plus morning light in 49 adolescents, 13% still met the diagnosis against 82% on the waitlist; Wescott et al. (JAMA Pediatrics, 2026; PMID 42008244), 86 adolescents with late sleep, an earlier sleep schedule with morning light glasses and evening blue-blocking glasses moved the clock 45 minutes earlier and lengthened weeknight sleep by 47 minutes; Facer-Childs et al. (Sleep Medicine, 2019; PMID 31202686), night owls, about 2 hours earlier sleep timing with light, meal, caffeine and exercise changes. Light alone against a credible control has mixed results: C.
Forbes et al., Cochrane (Cochrane Database of Systematic Reviews A review that searches for every study on a question using a method set in advance, then assesses them together., 2014; PMID 24574061), 11 trials: no effect of light therapy on sleep in dementia. Tan et al. (Sleep Medicine, 2022; PMID 35180479), 18 randomized trials, 1,012 older people with dementia: fewer night awakenings and better sleep quality with small to medium effects (g = 0.26 to 0.43), most outcomes low certainty. Morning-light trials: Dowling et al. (International Journal of Geriatric Psychiatry, 2005; PMID 16035127), 70 residents with Alzheimer disease, 1 hour of bright light in the morning or afternoon for 10 weeks, no difference in actigraphic nighttime sleep or daytime wake; Dowling et al. (International Psychogeriatrics, 2005; PMID 16050432), 46 residents, no overall improvement; Mishima et al. (Chronobiology International, 1998; PMID 9844752), 22 patients, less nighttime activity in vascular dementia but not Alzheimer disease; Ancoli-Israel et al. (Behavioral Sleep Medicine, 2003; PMID 15600135), more consolidated sleep with morning and with evening light. Mixed results: C.
Riemersma-van der Lek et al. (JAMA, 2008; PMID 18544724): 189 residents of 12 Dutch group care facilities, 87% with dementia, randomized by facility to whole-day bright (about 1,000 lux) or dim (about 300 lux) ceiling light, and by person to evening melatonin or placebo, for a mean of 15 months. Light slowed decline on the Mini-Mental State Examination by 0.9 points (a relative 5%), lowered depressive symptoms by 1.5 points and slowed the rise in daily-living limitations by 1.8 points a year; light with melatonin raised sleep efficiency by 3.5%. This is all-day ambient light, not timed morning light. The Cochrane review found the daily-living effect in one study only (PMID 24574061). One trial, not repeated: C.
Friedman et al. (Sleep Medicine, 2012; PMID 22406033): bright white light (about 4,200 lux) or dim red light (about 90 lux) for 30 minutes daily starting within 30 minutes of rising, for 2 weeks, with sleep hygiene for everyone. In the people with memory impairment, actigraphy and log total sleep time and time in bed fell on bright light, and the drop in sleep went with lower sleep efficiency and more waking after sleep onset; insomnia symptoms did not change. Caregivers improved in both groups alike. The authors concluded this regimen diminished sleep. The treated group did worse: D on Route 2 Human randomized trials have been run and did not show benefit on the stated outcome. One of the two routes to the lowest letter on EBL's scale..
Sander et al. (Chronobiology International, 2015; PMID 26181467): 29 healthy adults over 65 in Copenhagen, blue-enriched against blue-suppressed indoor light from 8 AM to 1 PM, crossover A trial design in which each participant receives both the treatment and the comparison, one after the other, and serves as their own control., 3 weeks each; sleep duration 7.44 against 7.31 hours (p = 0.289) and no change in melatonin profile; sleep quality scores improved in women only. Barroggi Constantino et al. (GeroScience, 2025; PMID 39821044): 36 healthy adults aged 60 or older at home, crossover of blue-enriched against standard white light 2 hours in the morning and 2 hours in the evening; longer morning exposure went with steadier rest-activity rhythms and less fragmented sleep, while evening light lengthened sleep latency and lowered sleep efficiency. Schubert et al. (European Geriatric Medicine, 2025; PMID 39627630): 15 hospitalized geriatric trauma patients, a daylight lamp from 8 AM to 1 PM for 6 days, crossover; no significant change in sleep or hormone rhythms. Small trials, mixed results: C.
Tanaka et al. (Journal of Occupational Health, 2011; PMID 21597232): 61 nurses on rapidly rotating shifts, randomized crossover, 10 minutes of bright light on workday mornings; sleepiness at 10:00 lower (Karolinska Sleepiness Scale -0.55), self-rated night sleep better, fatigue lower and mean reaction time on the psychomotor vigilance test faster; no difference in lapses, sleepiness at 14:00, depression or perceived errors and near misses. One trial, not repeated: C. The shift-work meta-analyses (Lam et al., Scientific Reports, 2021; PMID 34099750; Zhao et al., Scientific Reports, 2025; PMID 39747347) pool light given mainly during night shifts, which does not test morning light.
No randomized trial has assigned healthy adults to outdoor light within a fixed interval after waking and measured sleep, mood or daytime energy. The nearest trials used light boxes or lamps, in people with a sleep, circadian or memory disorder, and their results are graded in the rows above. Population studies linking more daytime light to better mood, sleep and survival are listed as excluded evidence and carry no letter. No trial on the stated claim: D on Route 1 No human randomized trial has been run, so the record rests on animal or mechanistic evidence only. One of the two routes to the lowest letter on EBL's scale..
Moving the body clock earlier in healthy adults (B). Sleep in insomnia (C), sleep timing in delayed sleep phase and late sleepers (C), nighttime sleep in dementia in care facilities (C), cognitive decline and daily function with whole-day bright ceiling light in group care homes (C), sleep in older adults without dementia (C), daytime sleepiness and reaction time in rotating-shift nurses (C). Sleep in older adults with memory impairment living at home (D, tested, harm found). Outdoor light within a fixed window after waking in healthy adults (D, no trial). Links between daytime light, mood and survival rest on population studies and carry no letter.
Why this letter
Why this gradeThe reasoning, and what the grade does not cover.
Grade B on circadian timing. In controlled trials in healthy adults, bright light in the hours after waking moved the evening melatonin rise earlier: 2.1 and 1.5 hours against 0.6 hours in dim light (Burgess 2003, PMID 12932084), and about as much as evening melatonin in a randomized double-blind protocol (Burke 2013, PMID 24179293); scheduled light shifted phase in older adults with insomnia (Friedman 2009, PMID 19187411).
WHY NOT Amelatonin timing is a marker of the clock, a surrogate, which caps the grade at B; and a moved clock did not translate into better sleep in the largest placebo-controlled morning trial (PMID 19187411). For sleep itself the letter is C: meta-analyses pooling morning and evening light show small gains (PMID 37002704; PMID 39733392; PMID 26606319), the best-controlled morning trial was null, and light added little beyond an earlier sleep schedule (PMID 21704557; PMID 29680419; PMID 24132057). In older adults with memory impairment at home, 30 minutes of bright light within 30 minutes of rising reduced sleep (PMID 22406033): D, harm found.
WHAT THIS GRADE DOES NOT COVERdepression, which is graded on the separate bright light therapy page; outdoor sunlight at a fixed time after waking in healthy adults, which no trial has tested; mood and energy in healthy people; jet lag; and long-term health or survival, where the evidence is population studies (PMID 39405349; PMID 34488088; PMID 34420891). The direction of the clock shift depends on where the light falls on each person's internal clock, not on minutes since waking (PMID 12717008).
A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →
Trials report an average. This box says whether any trial on this record looked at who the result applies to, and what it found.
For this record's Grade B · Subgroup tested, effect differedDowling et al. (International Psychogeriatrics, 2005; PMID 16050432) found only the residents with the most disrupted rest-activity rhythm responded, Mishima et al. (Chronobiology International, 1998; PMID 9844752) found a response in vascular dementia but not Alzheimer disease, and Sander et al. (Chronobiology International, 2015; PMID 26181467) found sleep quality improved in women but not men. A subgroup result shows who the effect appeared in within these trials. It does not change the letter.
For Dementia in care facilities: nighttime sleep with morning bright light, Grade C · Subgroup tested, effect differedDowling et al. (International Psychogeriatrics, 2005; PMID 16050432) found only residents with the most disrupted rest-activity rhythm improved, and Mishima et al. (Chronobiology International, 1998; PMID 9844752) found less nighttime activity in vascular dementia but not in Alzheimer disease. A subgroup result shows who the effect appeared in within these trials. It does not change the letter.
For Older adults without dementia: sleep with brighter morning or daytime indoor light, Grade C · Subgroup tested, effect differedSander et al. (Chronobiology International, 2015; PMID 26181467) found sleep quality scores improved during blue-enriched light in women, who had worse scores at baseline, but not in men. A subgroup result shows who the effect appeared in within these trials. It does not change the letter.
Evidence notes: randomized trial, meta-analysis of randomized trials
Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded: Timing of the body clock measured by dim light melatonin onset (DLMO) in saliva (surrogate)
Last reviewed: October 2026
The trial that would change this grade.
Positive trials of this shape from independent research groups would move this entry to A.
Why the current trials fall short
This would test the circulating claim directly. Two independent trials showing better objectively measured sleep or alertness could support A for that population.
ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Bright Light Therapy among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.
Search recruiting studies of Bright Light Therapy on ClinicalTrials.gov
Dose, form and timing
Measured outcome: the clock time at which melatonin rises in the evening, sampled in dim light before and after treatment (PMID 12932084; PMID 24179293). Sleep rows used wrist actigraphy, overnight polysomnography and sleep diaries or questionnaires (PMID 19187411; PMID 37002704; PMID 22406033); the shift-work row used a reaction-time test (PMID 21597232).
As studiedDose, form, population and duration for every use.
A grade describes the intervention that was tested. Where the product on the shelf differs from it, this says so.
Safety
In older adults with memory impairment living at home, 30 minutes of bright light starting within 30 minutes of rising cut total sleep time, with lower sleep efficiency and more waking at night, against dim red light (Friedman 2012, PMID 22406033). In 83 patients with winter depression given 10,000 lux for 30 minutes, side effects were mostly mild: nausea (15.9%), headache (8.4%) and jumpiness (8.8%); feeling overactive or elated emerged more often with morning light (Terman 1999, PMID 10584776). In non-seasonal depression, hypomania was more common on bright light than on control (risk ratio 4.91, number needed to harm 8) (Tuunainen 2004, PMID 15106233). In healthy older adults, evening light lengthened the time to fall asleep and lowered sleep efficiency (Barroggi Constantino 2025, PMID 39821044).
Cautions documented in human studies. Each caution on this record, sorted by what it rests on.
- Shorter sleep: in older adults with memory impairment, bright light soon after rising cut total sleep time and sleep efficiency (PMID 22406033)
- Side effects at 10,000 lux: nausea, headache and jumpiness, with feeling overactive or elated more often after morning light (PMID 10584776)
- Hypomania: more common on bright light than control in non-seasonal depression (risk ratio 4.91, number needed to harm 8) (PMID 15106233)
- Evening light: in healthy older adults, evening light lengthened time to fall asleep and lowered sleep efficiency (PMID 39821044)
None recorded.
None recorded.
None recorded.
Does not apply: human harm data are listed above.
Grade history
How this letter has changedLatest: No. 397 · October 2026 · First graded.
Morning bright light (light box or daylight) for sleep and the body clock now has its own record, graded use by use after a full PubMed search in October 2026: Body clock timing (melatonin onset) moved earlier, healthy adults (B); Insomnia: sleep measured by actigraphy, polysomnography and questionnaires (C); Delayed sleep phase and late sleepers: sleep timing and daytime function (C); Dementia in care facilities: nighttime sleep with morning bright light (C); Whole-day bright ceiling light in group care homes: cognitive decline and daily function (C); Older adults with memory impairment living at home: 30 minutes of bright light within 30 minutes of rising (D); Older adults without dementia: sleep with brighter morning or daytime indoor light (C); Rotating-shift nurses: daytime sleepiness and reaction time with brief morning light (C); Healthy adults: outdoor light within a fixed window after waking, for sleep, mood or energy (D). Moving the body clock earlier in healthy adults (B). Sleep in insomnia (C), sleep timing in delayed sleep phase and late sleepers (C), nighttime sleep in dementia in care facilities (C), cognitive decline and daily function with whole-day bright ceiling light in group care homes (C), sleep in older adults without dementia (C), daytime sleepiness and reaction time in rotating-shift nurses (C). Sleep in older adults with memory impairment living at home (D, tested, harm found). Outdoor light within a fixed window after waking in healthy adults (D, no trial). Links between daytime light, mood and survival rest on population studies and carry no letter. Applied the written grade definitions under the editor's standing instruction of October 2026 (Arnold Sandlow, D.C.).PMID 12932084 PMID 24179293 PMID 21704557 PMID 30084658 PMID 12717008 PMID 19187411 PMID 7717792 PMID 37374270 PMID 37002704 PMID 39733392 PMID 42263407 PMID 26606319
Every change to a letter on this site is dated and published. The full evidence log →
Sources
- Citations
- Every paper cited on this page is matched to its PubMed record on every build.
- Retractions
- None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
- Read against the papers
- October 2026. By a language model (AI-assisted reading), not yet reviewed by a clinician.
- Outside review
- Not yet done. No reviewer outside EBL has checked this record.
What each of these checks can and cannot show: evidence integrity.
The evidence, in full38 papers, each linked to its PubMed record.
Body clock: Burgess et al. (Journal of Biological Rhythms, 2003; PMID 12932084): 28 healthy young adults, dim light melatonin onset advanced 2.1 hours (continuous bright light), 1.5 hours (intermittent) and 0.6 hours (dim light) over 3 days of a sleep schedule moved 1 hour earlier each day. Burke et al. (Sleep, 2013; PMID 24179293): randomized double-blind protocol in 36 healthy adults; 3 hours of about 3,000 lux starting 1 hour before habitual waking advanced the clock about as much as 5 mg evening melatonin, and the two combined advanced it more. Sharkey et al. (Sleep Medicine, 2011; PMID 21704557): 25 young adults with late schedules, an earlier fixed sleep schedule advanced the clock with or without 1 hour of morning blue light. Crowley et al. (Chronobiology International, 2018; PMID 30084658): late bedtimes prevented the advance to morning light in adolescents. Khalsa et al. (Journal of Physiology, 2003; PMID 12717008): laboratory phase response curve in 21 healthy adults; light before the body temperature low point delayed the clock and light after it advanced it. Insomnia: Friedman et al. (Journal of the American Geriatrics Society, 2009; PMID 19187411): 51 adults aged 63.6 on average with primary insomnia, about 4,000 lux or 65 lux for 45 minutes in the morning or evening for 12 weeks with sleep hygiene; bright light no better than dim on polysomnography, actigraphy or logs, though it shifted circadian phase. Guilleminault et al. (Archives of Internal Medicine, 1995; PMID 7717792): 30 patients, only sleep hygiene with early morning light reached significant improvement. Yoon et al. (Medicina, 2023; PMID 37374270). Chambe et al. (Journal of Sleep Research, 2023; PMID 37002704); Wang et al. (Sleep and Breathing, 2024; PMID 39733392); Wasilah et al. (International Journal of Nursing Studies, 2026; PMID 42263407); van Maanen et al. (Sleep Medicine Reviews, 2016; PMID 26606319): 53 studies, 1,154 participants, sleep problems overall g = 0.39, circadian rhythm sleep disorders 0.41, insomnia 0.47, dementia 0.30, most effects small to medium. Delayed sleep phase: Faulkner et al. (Sleep Medicine Reviews, 2019; PMID 31108433); Rosenthal et al. (Sleep, 1990; PMID 2267478); Richardson et al. (Sleep Medicine, 2018; PMID 29680419); Wilhelmsen-Langeland et al. (Journal of Biological Rhythms, 2013; PMID 24132057); Gradisar et al. (Sleep, 2011; PMID 22131604); Wescott et al. (JAMA Pediatrics, 2026; PMID 42008244); Facer-Childs et al. (Sleep Medicine, 2019; PMID 31202686). Dementia: Forbes et al. (Cochrane Database of Systematic Reviews, 2014; PMID 24574061); Tan et al. (Sleep Medicine, 2022; PMID 35180479); Dowling et al. (International Journal of Geriatric Psychiatry, 2005; PMID 16035127); Dowling et al. (International Psychogeriatrics, 2005; PMID 16050432); Mishima et al. (Chronobiology International, 1998; PMID 9844752); Ancoli-Israel et al. (Behavioral Sleep Medicine, 2003; PMID 15600135); Riemersma-van der Lek et al. (JAMA, 2008; PMID 18544724); Friedman et al. (Sleep Medicine, 2012; PMID 22406033). Older adults without dementia: Sander et al. (Chronobiology International, 2015; PMID 26181467); Barroggi Constantino et al. (GeroScience, 2025; PMID 39821044); Schubert et al. (European Geriatric Medicine, 2025; PMID 39627630). Shift work: Tanaka et al. (Journal of Occupational Health, 2011; PMID 21597232); Lam et al. (Scientific Reports, 2021; PMID 34099750); Zhao et al. (Scientific Reports, 2025; PMID 39747347). Side effects: Terman and Terman (Journal of Clinical Psychiatry, 1999; PMID 10584776); Tuunainen et al. (Cochrane Database of Systematic Reviews, 2004; PMID 15106233). Windred et al. (Proceedings of the National Academy of Sciences, 2024; PMID 39405349): UK Biobank cohort of 88,905 adults who wore light sensors for a week; brighter days went with lower all-cause mortality over 8 years. A population study, listed as excluded evidence; it carries no letter.
How EBL searched for the trials (1 search)
The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.
(morning[tiab]) AND ("bright light"[tiab] OR "light therapy"[tiab] OR "light exposure"[tiab] OR "light treatment"[tiab] OR daylight[tiab] OR "blue light"[tiab] OR "blue-enriched"[tiab]) AND (sleep[tiab] OR circadian[tiab] OR melatonin[tiab] OR insomnia[tiab] OR actigraph*[tiab]) AND (randomized controlled trial[pt] OR randomized[tiab])PubMed watch: does a new study change the grade? (nothing new)
No new paper matching the searches behind this grade has been added to PubMed since October 2026.
Last run October 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.
Disclosure
Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.
Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy
© Evidence Based Longevity, Inc. All rights reserved
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →